MCHP:NASDAQMicrochip Technology Incorporated Analysis
Data as of 2026-03-10 - not real-time
$65.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Microchip Technology (MCHP) trades around $65, comfortably above its 20‑day SMA of 74.66 but still below the 200‑day SMA of 67.05, indicating a short‑term pullback within a longer‑term uptrend. The RSI of 26.7 and a bearish MACD histogram signal oversold conditions, while the price is perched near the computed support level of $61.68, suggesting a potential bounce if buying pressure returns. However, the stock’s beta of 2.16 and 30‑day volatility of over 40% highlight pronounced price swings, and a historic max drawdown of –36% underscores downside risk. Valuation metrics are stark: the DCF‑derived fair value of $39.27 is far below the market price, implying an upside‑downside profile of +33% but also indicating the market may be pricing in future growth that is not yet reflected in fundamentals. The company’s revenue grew 15.6% YoY with solid gross margins (55.4%) and operating margins (13.2%), yet it posted a negative profit margin (‑1.6%) and a trailing EPS of –$0.30, leading to a zero trailing P/E and a forward P/E of 24.5 versus an industry average of 36.9. The dividend yield of 2.8% looks attractive, but a payout ratio exceeding 300% and negative earnings raise serious concerns about sustainability.
Recent material news adds nuance: Barclays initiated coverage with an equal‑weight rating and an $80 price target, citing moderate correlation with industrial demand and a “more moderate” risk profile, while the company announced a quarterly cash dividend of $0.455 per share and will present at the Morgan Stanley TMT conference, highlighting new cybersecurity‑focused product lines. These developments, combined with a strong cash flow ($911M operating, $996M free) and a strategic push into secure embedded solutions, support a medium‑term upside narrative, but the high leverage (debt‑to‑equity 82) and ongoing earnings volatility temper long‑term enthusiasm.
Recent material news adds nuance: Barclays initiated coverage with an equal‑weight rating and an $80 price target, citing moderate correlation with industrial demand and a “more moderate” risk profile, while the company announced a quarterly cash dividend of $0.455 per share and will present at the Morgan Stanley TMT conference, highlighting new cybersecurity‑focused product lines. These developments, combined with a strong cash flow ($911M operating, $996M free) and a strategic push into secure embedded solutions, support a medium‑term upside narrative, but the high leverage (debt‑to‑equity 82) and ongoing earnings volatility temper long‑term enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI in oversold territory suggesting a possible short‑term rebound
- Bearish MACD histogram indicating continued downward pressure
- Proximity to the $61.68 support level and high short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- 15.6% revenue growth and solid operating margins
- Barclays $80 price target and equal‑weight rating
- Strategic focus on cybersecurity‑enabled embedded products
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Secular demand for embedded control solutions across automotive and industrial markets
- High leverage and negative earnings limiting upside
- Unsustainable dividend payout ratio despite attractive yield
Key Metrics & Analysis
Financial Health
Revenue Growth15.60%
Profit Margin-1.57%
P/E Ratio24.5
ROE-1.09%
ROA1.16%
Debt/Equity82.38
P/B Ratio5.4
Op. Cash Flow$911.0M
Free Cash Flow$996.4M
Industry P/E36.8
Technical Analysis
TrendBullish
RSI26.7
Support$61.68
Resistance$83.35
MA 20$74.66
MA 50$73.79
MA 200$67.05
MACDBearish
VolumeStable
Fear & Greed Index78.23
Valuation
Fair Value$39.27
Target Price$86.67
Upside/Downside33.33%
GradeOvervalued
TypeGrowth
Dividend Yield2.80%
Risk Assessment
Beta2.16
Volatility40.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.